A share price of Evolus Inc [EOLS] is currently trading at $12.62, up 7.22%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The EOLS shares have gain 9.74% over the last week, with a monthly amount drifted -8.28%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Evolus Inc [NASDAQ: EOLS] stock has seen the most recent analyst activity on January 29, 2024, when Barclays upgraded its rating to a Overweight and also boosted its price target to $16 from $10. Previously, Needham started tracking the stock with Buy rating on June 23, 2022, and set its price target to $18. On May 12, 2022, upgrade upgraded it’s rating to Equal Weight and revised its price target to $10 on the stock. Truist upgraded its rating to a Buy but stick to its price target of $11 on January 20, 2022. Mizuho upgraded its rating to a Buy but $15 remained the price target by the analyst firm on May 06, 2021. H.C. Wainwright reiterated a Buy rating for this stock on April 08, 2021, and upped its price target to $22. In a note dated February 24, 2021, Truist downgraded an Hold rating on this stock but restated the target price of $12.
Evolus Inc experienced fluctuations in its stock price throughout the past year between $7.07 and $15.43. Currently, Wall Street analysts expect the stock to reach $16 within the next 12 months. Evolus Inc [NASDAQ: EOLS] shares were valued at $12.62 at the most recent close of the market. An investor can expect a potential return of 26.78% based on the average EOLS price forecast.
Analyzing the EOLS fundamentals
Trailing Twelve Months sales for Evolus Inc [NASDAQ:EOLS] were 202.09M which represents 39.76% growth. Gross Profit Margin for this corporation currently stands at 0.69% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.31%, and Net Profit Margin reading is -0.31%. To continue investigating profitability, this company’s Return on Assets is posted at -0.33, Equity is 6.16 and Total Capital is -0.31. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-5.88.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.19 points at the first support level, and at 11.77 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.86, and for the 2nd resistance point, it is at 13.11.
Evolus Inc [EOLS] reported earnings per share of -$0.12 for its fiscal quarter that ended on 12/31/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.07/share, meaning a difference of -$0.05 and a surprise factor of -71.40%. By comparison, the stated earnings for the previous quarter ended on 9/30/2023 were -$0.16 per share as compared to estimates of -$0.17 per share, a difference of $0.01 representing a surprise of 5.90%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Evolus Inc [NASDAQ:EOLS] is 2.33. Further, the Quick Ratio stands at 2.10, while the Cash Ratio is 1.3. Considering the valuation of this stock, the price to sales ratio is 3.84.
Transactions by insiders
Recent insider trading involved MOATAZEDI DAVID,, that happened on Mar 27 ’24 when 6236.0 shares were sold., MOATAZEDI DAVID completed a deal on Mar 19 ’24 to sell 96566.0 shares. Meanwhile, Avelar Rui sold 27603.0 shares on Mar 19 ’24.
